We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$13.4B
AUM Growth
-$1.18B
(-8.1%)
Cap. Flow
-$624M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
7.94%
Holding
1,057
New
56
Increased
305
Reduced
416
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Innospec
IOSP
|
+$25.1M |
| 2 |
Haemonetics
HAE
|
+$24.2M |
| 3 |
Calix
CALX
|
+$22.2M |
| 4 |
MaxCyte
MXCT
|
+$21.3M |
| 5 |
FRG
Franchise Group, Inc.
FRG
|
+$21.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kulicke & Soffa
KLIC
|
+$37.4M |
| 2 |
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
|
+$32.3M |
| 3 |
Manhattan Associates
MANH
|
+$28.6M |
| 4 |
KRA
Kraton Corporation
KRA
|
+$28.3M |
| 5 |
GPX
GP Strategies Corp.
GPX
|
+$23.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.4% |
| 2 | Technology | 20.93% |
| 3 | Financials | 15.39% |
| 4 | Consumer Discretionary | 13.63% |
| 5 | Materials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPRO
276
DELISTED
Open Lending Corp
LPRO
| $15.9M | 0.12% |
441,401
-276,999
| -39% | -$10.6M |
|
277
BlueLinx
BXC
$613M
| $15.8M | 0.12% |
324,024
+181,024
| +127% | +$9.1M |
|
|
AAN
278
DELISTED
The Aaron's Company Inc
AAN
| $15.8M | 0.12% |
573,794
+78,808
| +16% | +$2.21M |
|
279
Federated Hermes
FHI
$4.36B
| $15.7M | 0.12% |
484,265
+9,047
| +2% | +$295K |
|
|
INFN
280
DELISTED
Infinera Corporation Common Stock
INFN
| $15.7M | 0.12% |
1,889,949
-504,770
| -21% | -$4.57M |
|
281
Ziff Davis
ZD
$1.96B
| $15.7M | 0.12% |
132,241
-13,110
| -9% | -$1.57M |
|
|
SKX
282
DELISTED
Skechers
SKX
| $15.7M | 0.12% |
372,556
-57,266
| -13% | -$2.83M |
|
283
UNIFI
UFI
$126M
| $15.7M | 0.12% |
714,006
-45,986
| -6% | -$1.05M |
|
284
Teradata
TDC
$2.71B
| $15.5M | 0.12% |
+270,310
| New | +$13.9M |
|
285
JetBlue
JBLU
$1.64B
| $15.4M | 0.12% |
1,009,821
-154,546
| -13% | -$2.37M |
|
286
Cleveland-Cliffs
CLF
$6.67B
| $15.4M | 0.12% |
779,022
-216,165
| -22% | -$4.93M |
|
|
CYBE
287
DELISTED
Cyberoptics Corp
CYBE
| $15.3M | 0.11% |
428,700
-43,000
| -9% | -$1.75M |
|
288
Pitney Bowes
PBI
$2.36B
| $15.1M | 0.11% |
2,092,051
-255,467
| -11% | -$2M |
|
289
PROG Holdings
PRG
$1.49B
| $15M | 0.11% |
357,537
+5,628
| +2% | +$253K |
|
|
ATRI
290
DELISTED
Atrion Corp
ATRI
| $15M | 0.11% |
21,496
-14
| -0.1% | -$9.29K |
|
|
ACH
291
Accendra Health
ACH
$83.1M
| $15M | 0.11% |
479,124
-238,026
| -33% | -$9.37M |
|
292
Diodes
DIOD
$4.17B
| $15M | 0.11% |
165,325
-121,205
| -42% | -$10.6M |
|
293
La-Z-Boy
LZB
$1.22B
| $14.9M | 0.11% |
463,373
+6,851
| +2% | +$236K |
|
294
NMI Holdings
NMIH
$3.28B
| $14.9M | 0.11% |
660,528
-148,754
| -18% | -$3.27M |
|
295
Matador Resources
MTDR
$7.74B
| $14.9M | 0.11% |
391,272
-81,399
| -17% | -$2.5M |
|
296
Resideo Technologies
REZI
$2.91B
| $14.8M | 0.11% |
598,548
+28,276
| +5% | +$822K |
|
297
PC Connection
CNXN
$2.15B
| $14.8M | 0.11% |
336,546
-19,774
| -6% | -$906K |
|
298
Lindblad Expeditions
LIND
$1.72B
| $14.7M | 0.11% |
1,008,968
+12,600
| +1% | +$177K |
|
299
Fossil Group
FOSL
$296M
| $14.7M | 0.11% |
1,237,822
+773,993
| +167% | +$10M |
|
300
Quanterix
QTRX
$121M
| $14.6M | 0.11% |
294,079
-1,000
| -0.3% | -$51.6K |
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Royce & Associates held 1,057 positions worth $13.4B, down 8.1% from $14.6B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Royce & Associates withdrew a net $624M in Q3 2021, closing 75 positions and reducing 416 holdings. Its most notable exit was SmileDirectClub, Inc. Class A Common Stock, an estimated $32.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
Against the trend, Royce & Associates opened a new position in Calix worth $23.8M.
- Royce & Associates's largest Q3 2021 buy was Calix: 480,993 shares worth $23.8M.
- Royce & Associates added most to Innospec in Q3 2021, an estimated $25.1M increase.
- Royce & Associates's biggest Q3 2021 reduction was Kulicke & Soffa, cutting an estimated $37.4M.
- Royce & Associates fully exited SmileDirectClub, Inc. Class A Common Stock in Q3 2021, selling an estimated $32.3M.
- Royce & Associates's ten largest holdings make up 7.9% of its $13.4B portfolio in Q3 2021.
- Royce & Associates opened 56 new positions and closed 75 in Q3 2021.
- Royce & Associates's portfolio value fell 8.1% quarter-over-quarter to $13.4B.
Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.